Biohope attracts investors

A financing round was carried out through a crowdfunding campaign that attracted the investment of a total of 36 investors.

Biohope, a Spanish biotechnology company focused on the development of diagnostic solutions for the personalization of treatments in inflammation diseases, have recently and successfully raised capital to adapt the in vitro diagnostic kit-Immunobiogram® for the personalization of the treatment in patients with Rheumatoid Arthritis.

The research and development work to adapt the kit will begin in January 2018, and the technical validation of the kit in rheumatoid arthritis patients’ samples is expected in the first quarter of 2020, with the participation of several European hospitals.

 

Nota de prensa (en español)

2018-05-28T16:59:21+00:00January 10th, 2018|Awards and Recognitions|Comments Off on Biohope attracts investors